Literature DB >> 29428104

Management of occluded self-expanding biliary metal stents in malignant biliary disease.

Simon Nennstiel1, Isolde Tschurtschenthaler1, Bruno Neu2, Hana Algül1, Monther Bajbouj1, Roland M Schmid1, Stefan von Delius1, Andreas Weber3.   

Abstract

BACKGROUND: Occlusion of self-expanding metal stents (SEMS) in malignant biliary obstruction occurs in up to 40% of patients. This study aimed to compare the different techniques to resolve stent occlusion in our collective of patients.
METHODS: Patients with malignant biliary obstruction and occlusion of biliary metal stent at a tertiary referral endoscopic center were retrospectively identified between April 1, 1994 and May 31, 2014. The clinical records were further analyzed regarding the characteristics of patients, malignant strictures, SEMS, management strategies, stent patency, subsequent interventions, survival time and case charges.
RESULTS: A total of 108 patients with biliary metal stent occlusion were identified. Seventy-nine of these patients were eligible for further analysis. Favored management was plastic stent insertion in 73.4% patients. Second SEMS were inserted in 12.7% patients. Percutaneous transhepatic biliary drainage and mechanical cleansing were conducted in a minority of patients. Further analysis showed no statistically significant difference in median overall secondary stent patency (88 vs. 143 days, P = 0.069), median survival time (95 vs. 192 days, P = 0.116), median subsequent intervention rate (53.4% vs. 40.0%, P = 0.501) and median case charge (€5145 vs. €3473, P = 0.803) for the treatment with a second metal stent insertion compared to plastic stent insertion. In patients with survival time of more than three months, significantly more patients treated with plastic stents needed re-interventions than patients treated with second SEMS (93.3% vs. 57.1%, P = 0.037).
CONCLUSIONS: In malignant biliary strictures, both plastic and metal stent insertions are feasible strategies for the treatment of occluded SEMS. Our data suggest that in palliative biliary stenting, patients especially those with longer expected survival might benefit from second SEMS insertion. Careful patient selection is important to ensure a proper decision for either management strategy.
Copyright © 2018 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biliary tract diseases; Biliary tract neoplasms; Complications; Endoscopic retrograde cholangiopancreatography; Self-expanding metal stents

Mesh:

Substances:

Year:  2018        PMID: 29428104     DOI: 10.1016/j.hbpd.2018.01.016

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  3 in total

1.  Comparison of the Clinical Outcomes of Suprapapillary and Transpapillary Stent Insertion in Unresectable Cholangiocarcinoma with Biliary Obstruction.

Authors:  Jongbeom Shin; Jin-Seok Park; Seok Jeong; Don Haeng Lee
Journal:  Dig Dis Sci       Date:  2019-10-04       Impact factor: 3.199

2.  Biliary Stenting for Malignant Biliary Obstruction Secondary to Pancreatic Cancer.

Authors:  Alexandru Constantinescu; Vasile Şandru; Madalina Ilie; Bogdan Silviu Ungureanu; Dan IonuŢ Gheonea; Tudorel Ciurea; Sergiu Marian Cazacu; Cristin-Constantin Vere; Gabriel Constantinescu
Journal:  Curr Health Sci J       Date:  2020-12-31

Review 3.  Endoscopic Reintervention for Recurrence of Malignant Biliary Obstruction: Developing the Best Strategy.

Authors:  Mamoru Takenaka; Masatoshi Kudo
Journal:  Gut Liver       Date:  2022-02-23       Impact factor: 4.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.